## Abstract In a prospective randomized study, 25 patients with benign bone tumors were surgically treated with either bioactive glass S53P4 (BG) or autogenous bone (AB) as bone graft material. Xβrays were taken preoperatively and postoperatively at 2 weeks and at 3, 8, 12, 18, 24, and 36 months. I
β¦ LIBER β¦
OSTEOCONDUCTIVE MATERIALS AND THEIR ROLE AS SUBSTITUTES FOR AUTOGENOUS BONE GRAFTS
β Scribed by Cornell, Charles N.
- Book ID
- 121989675
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 803 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0030-5898
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Bioactive glass and autogenous bone as b
β
Nina C. Lindfors; Jouni T. HeikkilΓ€; Ilona Koski; Kimmo Mattila; Allan J. Aho
π
Article
π
2008
π
John Wiley and Sons
π
English
β 191 KB
Bone substitutes and growth factors as a
β
Mats Hallman; Andreas Thor
π
Article
π
2008
π
John Wiley and Sons
π
English
β 671 KB
Grafts and Graft Materials as Vascular S
β
L. Berardinelli
π
Article
π
2006
π
Elsevier Science
π
English
β 411 KB
Osteoconductive and hemostatic propertie
β
Tabata, Masashi ;Shimoda, Toru ;Sugihara, Kazumasa ;Ogomi, Daisuke ;Serizawa, Ta
π
Article
π
2003
π
John Wiley and Sons
π
English
β 827 KB
## Abstract The biologic behavior of hydroxyapatite formed on/in agarose (HA/agarose) gels with the use of a novel alternate soaking process was compared with commercially available Bone Ject (TrueβBone ceramicβcollagen combined boneβgraft material, Koken, Japan) as a filler for the toothβextractio
Material characterization and biological
β
Jeffrey Michael Toth; Robert N. Blumenthal
π
Article
π
1993
π
Springer
π
English
β 212 KB
Biomaterials for Tissue Engineering Appl
β
Burdick, Jason A.; Mauck, Robert L.
π
Article
π
2011
π
Springer Vienna
β 343 KB